Processa presents at Sidoti conference; no material financial data disclosed

Processa Pharmaceuticals, Inc.

Company presented on August 17, 2023, at the Sidoti Micro-Cap Virtual Conference.
David Young, Pharm.D., Ph.D., presented the corporate update during Track 2 at 11:30 AM ET.
Presentation is available on Processa's website under the Investors section.
No specific clinical trial results, financial guidance, or pipeline changes were detailed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.